Preliminary Characterization of Extracellular Vesicles From Auditory HEI-OC1 Cells.

CONCLUSIONS: Altogether, the results suggest that EVs from HEI-OC1 cells could be advantageously used as biological nanocarriers for the delivery of specific molecules and pharmacological drugs into the inner ear. PMID: 31092033 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31092033?dopt=Abstract

Source: The Annals of Otology, Rhinology, and Laryngology - May 18, 2019 Category: ENT & OMF Authors: Kalinec PhD GM, Cohn BSc W, Whitelegge PhD JP, Faull PhD KF, Kalinec PhD F Tags: Ann Otol Rhinol Laryngol Source Type: research

More News: Dexamethasone | ENT & OMF | Nanotechnology